Table 4 Datasets used in this study. For the number of strains and SNPs, the final numbers after all filtering are provided
Drug name | Line of therapy | Pharmacological group | Number of strains | Number (fraction) of resistant strains | Number of SNPs (features) |
|---|---|---|---|---|---|
STR | First line | Aminoglycosides | 4,726 | 1158 (24,5%) | 24,425 |
AMK | Second line | Aminoglycosides | 1,149 | 208 (18,1%) | 18,864 |
CAP | Second line | Aminoglycosides | 1,086 | 205 (18,9%) | 17,045 |
KAN | Second line | Aminoglycosides | 1,362 | 297 (21,8%) | 17,335 |
OFL | Second line | Fluoroquinolones | 795 | 307 (38,6%) | 14,185 |
ETH | Second line | Nicotinamide derivative | 571 | 210 (36,8%) | 12,974 |
Total | 4,869 | Â | 24,425 | ||